Sign in

RECURSION PHARMACEUTICALS, INC.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total revenue 0.07 0.06 0.04 0.04 0.01 0.00 0.00
Cost of revenue 0.12 0.05 0.04 0.05 0.01 0.06 0.05
Gross profit -0.05 0.01 0.00 -0.01 0.01 0.00 -0.04
Total operating expenses + 0.60 0.49 0.35 0.24 0.19 0.09 0.06
Operating income -0.65 -0.48 -0.35 -0.25 -0.18 -0.08 -0.06
Non-operating income (net) 0.00 0.01 0.02 0.01 0.00 0.00 0.00
Income before tax -0.64 -0.46 -0.33 -0.24 -0.19 -0.09 -0.06
Income tax expense 0.00 0.00 0.00 0.00 -0.01 0.00 0.00
Net income -0.64 -0.46 -0.33 -0.24 -0.18 -0.09 -0.06
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.01 0.04 0.01 0.02 0.01 0.00 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.01 0.03 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.00 0.03 0.03 0.02 0.02 0.02 0.01 0.01
Gross profit -0.01 0.01 -0.02 0.00 -0.01 -0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 -0.01
Total operating expenses + 0.12 0.12 0.15 0.18 0.18 0.18 0.11 0.11 0.10 0.10 0.10 0.08 0.07 0.06 0.06 0.06 0.05 0.07 0.05 0.04 0.03 0.03 0.02 0.02 0.02
Operating income -0.13 -0.11 -0.17 -0.18 -0.19 -0.18 -0.10 -0.10 -0.10 -0.10 -0.10 -0.08 -0.07 -0.06 -0.06 -0.07 -0.06 -0.06 -0.05 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02
Non-operating income (net) 0.01 0.00 0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.12 -0.11 -0.16 -0.17 -0.20 -0.18 -0.10 -0.10 -0.09 -0.10 -0.09 -0.08 -0.07 -0.06 -0.06 -0.07 -0.06 -0.06 -0.05 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.12 -0.11 -0.16 -0.17 -0.20 -0.18 -0.10 -0.10 -0.09 -0.09 -0.09 -0.08 -0.07 -0.06 -0.06 -0.07 -0.06 -0.06 -0.05 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total cash and short-term investments + 0.74 0.59 0.39 0.55 0.52 0.26 0.07
Accounts receivable, net 0.02 0.05 0.00 0.00 0.01 0.00 0.00
Inventories 0.00 0.00 0.00 0.01 0.01
Other current assets 0.04 0.07 0.04 0.02 0.01 0.00 0.01
Total current assets 0.81 0.71 0.44 0.57 0.53 0.27 0.08
Total non-current assets + 0.66 0.73 0.22 0.13 0.08 0.03 0.03
Total assets 1.47 1.45 0.65 0.70 0.61 0.30 0.10
Total current liabilities + 0.15 0.19 0.09 0.10 0.05 0.02 0.01
Total non-current liabilities + 0.20 0.23 0.10 0.12 0.02 0.48 0.22
Total liabilities 0.34 0.41 0.19 0.22 0.07 0.50 0.23
Total stockholders' equity + 1.13 1.03 0.46 0.49 0.54 -0.21 -0.12
Common shares outstanding 447 274 208 176 170 166 166
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 0.65 0.74 0.66 0.53 0.50 0.59 0.43 0.47 0.30 0.39 0.39 0.41 0.47 0.55 0.45 0.52 0.59 0.52 0.58 0.63 0.21 0.26 0.00 0.00 0.07
Accounts receivable, net 0.01 0.02 0.02 0.02 0.05 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01
Other current assets 0.04 0.04 0.03 0.04 0.04 0.07 0.04 0.05 0.04 0.04 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.01 0.00
Total current assets 0.71 0.81 0.71 0.59 0.58 0.71 0.47 0.52 0.34 0.44 0.41 0.43 0.49 0.57 0.48 0.55 0.62 0.53 0.60 0.65 0.22 0.27 0.07
Total non-current assets + 0.63 0.66 0.69 0.72 0.72 0.73 0.25 0.25 0.21 0.22 0.22 0.24 0.14 0.13 0.13 0.13 0.11 0.08 0.06 0.05 0.05 0.03 -0.07
Total assets 1.34 1.47 1.40 1.30 1.31 1.45 0.73 0.78 0.56 0.65 0.63 0.67 0.63 0.70 0.61 0.67 0.73 0.61 0.66 0.70 0.27 0.30
Total current liabilities + 0.13 0.15 0.16 0.16 0.14 0.19 0.11 0.09 0.07 0.09 0.09 0.11 0.09 0.10 0.08 0.10 0.09 0.05 0.04 0.03 0.03 0.02
Total non-current liabilities + 0.19 0.20 0.20 0.22 0.23 0.23 0.09 0.11 0.08 0.10 0.10 0.08 0.11 0.12 0.14 0.14 0.16 0.02 0.02 0.03 0.48 0.48
Total liabilities 0.31 0.34 0.35 0.38 0.37 0.41 0.20 0.19 0.16 0.19 0.19 0.20 0.20 0.22 0.22 0.23 0.24 0.07 0.06 0.06 0.50 0.50
Total stockholders' equity + 1.02 1.13 1.05 0.92 0.93 1.03 0.52 0.58 0.40 0.46 0.44 0.47 0.43 0.49 0.39 0.44 0.49 0.54 0.60 0.64 -0.23 -0.21 0.08
Common shares outstanding 529 527 447 417 403 336 283 242 236 233 214 201 192 186 173 172 171 169 169 168 168 167 169 168 168
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Operating cash flow + -0.37 -0.36 -0.29 -0.08 -0.16 -0.05 -0.06
Cash flow from investing + -0.02 0.26 -0.01 0.19 -0.27 -0.01 0.00
Cash flow from financing + 0.52 0.30 0.14 0.15 0.46 0.25 0.12
Change in cash 0.13 0.21 -0.16 0.26 0.03 0.19 0.06
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + -0.08 -0.05 -0.12 -0.08 -0.13 -0.12 -0.06 -0.08 -0.10 -0.07 -0.07 -0.07 -0.07 -0.04 -0.05 -0.06 0.08 -0.06 -0.03 -0.03 -0.03 0.01 -0.02 -0.02 -0.02
Cash flow from investing + 0.00 0.00 0.00 -0.01 -0.01 0.28 0.00 0.00 -0.01 0.00 0.00 0.00 -0.01 -0.01 0.05 0.00 0.14 -0.05 -0.19 -0.01 -0.02 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.13 0.25 0.10 0.04 0.01 0.02 0.26 0.01 0.08 0.05 0.00 0.00 0.15 0.00 0.00 0.00 0.00 -0.01 0.46 0.00 0.01 0.23 0.00 0.01
Change in cash -0.08 0.08 0.13 0.02 -0.10 0.17 -0.05 0.18 -0.10 0.00 -0.02 -0.07 -0.08 0.09 0.00 -0.05 0.22 -0.11 -0.24 0.42 -0.05 0.01 0.21 -0.02 -0.01
4 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Operating Cashflow

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Change In Inventory

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Net Income

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Stock Based Compensation

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Cashflow From Financing

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Cashflow From Investment

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Capital Expenditures

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
8 days ago